The pace of development for CRISPR-based infectious disease assays increased as the pandemic progressed, more funding became available, and collaboration accelerated.
The test will be designed to run on a portable device that can ultimately be rolled out to point-of-need settings such as doctors' offices and workplaces.
The grant was awarded as part of DARPA's Epigenetic Characterization and Observation program, which aims to develop new approaches to epigenetic analysis.
Two research groups analyzed ancient DNA samples from across the Arctic to tease out how populations in Siberia and North America are related to one another.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
